Decreased Urine N6-methyladenosine level is closely associated with the presence of diabetic nephropathy in type 2 diabetes mellitus
BackgroundTo investigate the dynamic changes of urine N6-methyladenosine (m6A) levels in patients with type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN) and evaluate the clinical significance.MethodsFirst, the levels of urine m6A were examined and compared among 62 patients with T2DM, 70...
Main Authors: | Shu-jun Wan, Qiang Hua, Yu-jie Xing, Yi Cheng, Si-min Zhou, Yue Sun, Xin-ming Yao, Xiang-jian Meng, Jin-han Cheng, Han Wu, Qing Zhai, Yan Zhang, Xiang Kong, Kun Lv |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.986419/full |
Similar Items
-
Analysis of Urine Podocalyxin in Type 2 Diabetes Mellitus Subjects With and Without Diabetic Nephropathy
by: Jusni Ekasari Pelu, et al.
Published: (2023-04-01) -
The significance of urinary markers in the evaluation of diabetic nephropathy
by: Cvetković Tatjana, et al.
Published: (2008-01-01) -
Use and isolation of urinary exosomes as biomarkers for diabetic nephropathy
by: Luca eMusante, et al.
Published: (2014-09-01) -
The Heparanase Inhibitor (Sulodexide) Decreases Urine Glycosaminoglycan Excretion and Mitigates Functional and Histological Renal Damages in Diabetic Rats
by: Roshan-Milani S., et al.
Published: (2019-05-01) -
Potential value of three-dimensional ultrasonography in diagnosis of diabetic nephropathy in Chinese diabetic population with kidney injury
by: Nan Li, et al.
Published: (2020-06-01)